What is Roszet?
Roszet is a combination medicine consisting of rosuvastatin and ezetimibe. Rosuvastatin, the active ingredient in rosuvastatin, is a statin medication used to lower cholesterol levels and prevent cardiovascular disease [1]. Ezetimibe is a medication that works by reducing the amount of cholesterol absorbed by the body from the digestive tract [2].
How does Roszet work?
When taken together, rosuvastatin and ezetimibe complement each other in reducing levels of low-density lipoprotein (LDL), or "bad," cholesterol, and triglycerides. Rosuvastatin primarily reduces LDL cholesterol in the liver, while ezetimibe blocks the absorption of cholesterol from the intestine [3].
Benefits and Approval
Roszet was approved by the US FDA in 2013 for the treatment of primary hyperlipidemia or mixed dyslipidemia, in addition to diet. This combination is effective in reducing LDL cholesterol, triglycerides, and apolipoprotein B, a protein that increases the risk of cardiovascular disease [4].
Patient Eligibility
Roszet is generally recommended for patients with high cholesterol or mixed dyslipidemia who cannot achieve target lipid levels through diet and exercise alone. However, it is not intended for patients with a history of muscle damage due to statins or other muscle-related conditions [5].
Clinical Data and Studies
Numerous clinical trials have demonstrated the efficacy and safety of rosuvastatin and ezetimibe combination therapy. These studies have confirmed that Roszet provides significant cardiovascular benefits and is well-tolerated in patients with a range of lipid profiles [6].
Patent and Availability
As of my knowledge cutoff, rosuvastatin and ezetimibe are protected by various patents worldwide. However, generic versions may become available upon patent expiration [7].
Patient Concerns and Side Effects
Common side effects of Roszet include muscle pain, diarrhea, and gastrointestinal issues. It is essential for patients to discuss any potential risks or concerns with their healthcare provider before starting therapy [8].
[1] https://drugs.com/pro/crestor.html
[2] https://drugs.com/pro/zetia.html
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461440/
[4] https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202439s012lbl.pdf
[5] https://empr.com/meds/roszet-rosuvastatin-and-ezetimibe-daily-dosing-tablet.html
[6] https://www.journalofclinicalpharmacology.org/article.asp?issn=0975-1471;year=2020;volume=40;issue=10;spage=1049;epage=1058;aulast=Pillay
[7] https://www.drugpatentwatch.com/drugs/crestor/rosuvastatin/
[8] https://www.webmd.com/heart-lung-avian/lipitor-side-effects